{
  "ADD_TRANSACTION": "Ajouter un enregistrement",
  "SEQUENCE_NUM": "fr_Sequence Number",
  "NEW":"Nouvelle",
  "EXISTING":"Existant",
  "DATE_SUBMITTED": "fr_Date Submitted (YYYY-MM-DD)",
  "SEQUENCE_DESCRIPT": "fr_Regulatory Transaction Description",
  "IS_ACTCHANGES": "fr_Same as Regulatory Activity Contact for this Submission?",
  "COMPANY_ID": "ID d'entreprise",
  "DOSSIER_ID": "ID de dossier",
  "DOSSIER_NAME": "fr_Dossier Name",
  "IS_ECTD": "fr_Is this an eCTD transaction?",
  "IS_SOLICITED": "Cette information est-elle sollicitée?",
  "SOLICITED_RQ": "Demandeur d’information sollicitée",
  "SOLICITED_RQ_OTHER": "fr_Other Requester Details",
  "REP_CONTACT_INFO": "fr_Main Contact Information",
  "PROJ_MANAGER_NAME": "Responsable de projet réglementaire, si connu",
  "DATED": "Daté",
  "START_DATE": "Date de début",
  "END_DATE": "Date de fin",
  "REG_ACTIVITY": "fr_Regulatory Activity",
  "REG_ACTIVITY_TYPE": "Type d'activité réglementaire",
  "SEQUENCE_TYPE": "Description de transactions de réglementation",
  "VERSION_NO": "fr_Version Number",
  "BRIEF_DESC": "Brève description",
  "BRIEF_DESC_CHANGE": "fr_Brief Description of change",
  "ADMINISTRATIVE": "Administrative",
  "BENEFIT_RISK_ASSESS": "Benefit Risk Assessment",
  "CANCEL_LETTER": "Cancellation Letter",
  "CHANGE_TO_DIN": "Change to DIN",
  "COMMENTS_NOC": "Comments on Notice of Decision",
  "COMMENTS_SUMMARY_BASIS": "Comments on Summary Basis of Decision (SBD)",
  "COMMENTS_REGULARTORY_DECISION": "Comments on Regulatory Decision Summary",
  "DIN_DISCONTINUED": "Notification of Discontinued Sale (DIN Cancellation)",
  "DRUG_NOTIF_FORM": "Drug Notification Form",
  "FOR_PERIOD": "For Period of",
  "INITIAL": "INITIAL",
  "MEETING_MINUTES": "Minutes of Meeting",
  "NOTIFICATION_CHANGE": "Notification of Change in Benefit-Risk Profile",
  "NOTIFICATION_INTERRUPT_SALE":"Notification Interruption of Sale",
  "PANDEMIC_APPL": "Pandemic Application",
  "POST_CLEARANCE_DATA": "Post Clearance Data",
  "POST_MARKET_SURV": "Post Marketing Surveillance",
  "POST_NOC_CHANGE": "Post NOC Change",
  "POST_AUTH_DIV1_CHANGE": "Post-Authorization Division 1 Change",
  "PRESUB_MEETING_PKG": "Submission Meeting Package",
  "PRESUB_MEETING_RQ": "Submission Meeting Request",
  "PRIORITY_REVIEW_RQ": "Priority Review Request",
  "PRISTINE_PM": "Pristine PM",
  "PRISTINE_PM_2LANG": "Pristine PM - Second Language",
  "ADVISEMENT_LETTER_RESPONSE": "Response to Advisement Letter",
  "CLIN_CLARIF_RESPONSE": "Response to Clinical Clarification Request",
  "EMAIL_RQ_RESPONSE": "Response to e-mail Request ",
  "LABEL_CLARIF_RESPONSE": "Response to Labeling Clarification Request",
  "MHPD_RQ_RESPONSE": "Response to MHPD Request",
  "NOC_RESPONSE": "Response to NOC/c-QN",
  "NOD_RESPONSE": "Response to NOD",
  "NON_RESPONSE": "Response to NON",
  "NOL_RESPONSE": "Response to NOL",
  "PROCESSING_CLARIF_RESPONSE": "Response to Processing Clarification Request",
  "QUAL_CLIN_CLARIF_RESPONSE": "Response to Quality and Clinical Clarification Request",
  "QUAL_CLARIF_RESPONSE": "Response to Quality Clarification Request",
  "SCREENING_ACCEPT_RESPONSE": "Response to Screening Acceptance Letter",
  "SCREENING_CLARIF_RESPONSE": "Response to Screening Clarification Request",
  "SDN_RESPONSE": "Response to SDN",
  "PHONE_RQ_RESPONSE": "Response to Telephone Request",
  "RISK_COMMUN_DOC": "Risk Communication Document",
  "RMP_VERSION_DATE": "RMP version #",
  "SIGNAL_WORK_UP": "Signal Work Up",
  "UNSOLICITED_DATA": "Unsolicited Data",
  "YEAR_LIST_OF_CHANGE": "Year, list of change number (for example: 2012, 15, 19a,….)",
  "NONCLIN_CLARIF_RESPONSE": "Response to Non-clinical Clarification Request ",
  "BE_CLARIF_RESPONSE": "Response to BE Clarification Request",
  "RECON_DECIS_LTR_INTENT": "Reconsideration of Decision - Letter of Intent",
  "RECON_DECIS_RQ_RECON":  "Reconsideration of Decision - Request for Reconsideration",
  "RECON_DECIS_OTHER_INFO": "Reconsideration of Decision - Other Information",
  "LABEL_PREAPPROVAL_2LANG":"Second Language Label - Pre-Approval",
  "LIFECYCLE_TITLE": "Détails de la transaction",
  "REG_CONTACT_THIS": "Personne-ressource pour cette activité réglementaire",
  "REG_ACT_CONTACT": "fr_Regulatory Activity Contact",
  "TRANSACTION_HDING": "Information Réglementairen",
  "LOAD_TRANSACTION": "Charger un fichier de transaction réglemetaire",
  "COMPANY_INFO": "A. Information d'entreprise",
  "ADDRESS_INFO": "B. Information d'adresse",
  "COMPANY_REP_THIS": "C. Représentative de l'entrepise",
  "GENERATE_FINAL": "Générer le XML final",
  "CONFIRM_CONTACT_VALID": "Je confirme que l'information de la personne-ressource de l’activité réglementaire ci-dessus sont valides.",
  "YEAR_CHANGE": "Year of the change, List Description",
  "REG_ACTIVITY_INSTRUCT":"Regulatory Activity Contact Instructions",
  "SAVE_INSTRUCT": "Transaction File Save Instructions",
  "CLARIF_RESPONSE":"Response to Clarification Request",
  "CORR_PATENT_MED":"Correspondence - Patented Medicines",
  "ALLEGATION_NOTICE":"Notice of allegation",
  "FORM_IV":"Form IV",
  "FORM_V":"Form V",
  "CONSENT_LTR":"Consent Letter",
  "DATA_PROTECT_CORRESP":"Correspondence - Data Protection",
  "CHOOSE_REQUEST":"Choose a requester",
  "TRANSACT_INSTRUCT":"Regulatory Transaction Instructions",
  "LIST_DESCRIPT":"List Description",
  "SEQUENCE_CLEANUP":"eCTD Dossier Clean-up",
  "REQUESTER_NAME":"Nom du demandeur",
  "DEFER_FEES":" Un paiement différé est demandé avec cette transaction",
  "DEFER_STATEMENT":"La déclaration à l’appui de la demande de report de paiement est jointe.",
  "FEE_REMISSION":"Une remise de frais est demandé avec cette transaction",
  "STATEMENT_REVENUE":"Une déclaration signée par le responsable des affaires financières du demandeur est jointe pour attester que les frais payables sont plus élevés que 10% des revenus bruts anticipés.",
  "SUB_CLASS":"fr_Submission Class",
  "FEE_AMOUNT":"fr_Fees",
  "FEE_DESCRIPTION":"fr_Submission Description",
  "REMISSION_ELIGIBLE":"fr_You are eligible to apply for fee remission. The submission fee is greater than 10% of anticipated gross revenues.",
  "REMISSION_INELIGIBLE":"fr_You are not eligible to apply for fee remission. The submission fee is less than 10% of anticipated gross revenues.",
  "IS_FEE_TRANSACTION":"fr_Are new or revised fees associated with this transaction?",
  "REGULATORY_FEES":"fr_Fees",
  "GROSS_REVENUE":"fr_Anticipated gross revenue for this drug product during the fee verification period",
  "TEN_PERCENT_REVENUE": "fr_10% of anticipated gross revenue",
  "REQUIRED_DOC":"fr_Required Documentation",
  "SUPPORTING_DOC":"fr_Please include the required signed statement AND at least one of the support documentation to establish that the applicable fee payable is greater than 10% of the anticipated gross revenue from sales of the drug product in Canada during the fee verification period.",
  "EST_MARKET_SHARE":"fr_Estimated market share (that is [i.e.], product's market potential compared to the total market for similar products in Canada)",
  "SIMILAR_PRODUCT":"fr_Comparison to similar products on the Canadian market or other similar markets (e.g., United States, European Union)",
  "SALES_HISTORY":"fr_Sales history prior to product upgrades or sales history of similar products",
  "MARKETING_PLAN":"fr_Marketing plan/product plan for the drug product",
  "AVG_SALES":"fr_Average sale price and demand",
  "FEES_LESS10K":"Des frais de 10 000 $ ou moins doivent être soumis au moment du dépôt de la présentation, le supplément ou la demande. S’il vous plaît remplir le formulaire Détails du paiement en avance pour présentations de drogues et fiches maîtresses.",
  "ADVANCE_PAYMENT":"fr_Advance Payment Details for Drug Submissions and Master Files.",
  "SPONSOR_INVOICE":"fr_Review fees must not be included with the submission, supplement or application. Sponsors will be invoiced for fees of more than $10,000.",
  "PAYMENT_METHODS":"fr_Please select all the payment methods you intend to use",
  "ONE_PAYMENT_METHOD":"fr_Please select all the payment methods you intend to use",
  "DEFER_INSTRUCT":"fr_Deferral of payment Instructions",
  "REMISSION_INSTRUCT":"fr_Fee remission Instructions",
  "CLASS_INSTRUCT":"fr_Submission Class Instructions",
  "PRODUCT_INSTRUCT":"fr_Product Name Instructions",
  "LIFECYCLE_INSTRUCT":"fr_Lifecycle Management Table Instructions",
  "SEQUENCE_INSTRUCT":"fr_Sequence Number Instructions",
  "CONTROL_INSTRUCT":"fr_Control Number Instructions",
  "COMPANY_INSTRUCT":"fr_Company Name Instructions",
  "COMPANY_ID_INSTRUCT":"fr_Company ID Instructions",
  "DOSSIER_ID_INSTRUCT":"fr_Dossier ID Instructions",
  "ADMIN_COMP_INSTRUCT": "fr_Administrative Submission or Component Instructions",
  "PLEASE_REMIT":"Veuillez payer les frais de traitement de la remise de 590$ en utilisant les détails du paiement en avance pour présentations de drogues et fiches maîtresses.",
  "APPLY_DEFER":"fr_You are applying for a deferral. Please send no payment with this form.",
  "BANK_DRAFT":"Traite bancaire internationale",
  "MONEY_ORDER":"Mandat",
  "CHEQUE":"Chèque",
  "CREDIT":"fr_Mastercard / Visa / Amex / Visa Debit / JCB International",
  "BANK_WIRE":"Transfert bancaire (incluez la confirmation de la banque)",
  "EXISTING_CREDIT":"Paiement au moyen d’un crédit existant",
  "PREFEERED_OPTION":"fr_Bill Payment Service Option (preferred method)",
  "REG_TRANSACT":"fr_Regulatory Transaction",
  "LIFE_REC":"Détails de l'enregistrement du transaction",
  "ONELIFEREC": "fr_One transaction details record is required.",
  "SAVELIFEREC": "Un enregistrement des détails de la transaction est nécessaire pour enregistrer.",
  "LIFECYCLECTRL.LIFECYCLEDETAILSFORM":"fr_with a Transaction Details Record",
  "IS_NEW_ACTIVITY":"fr_Is this transaction for a new or existing regulatory activity?",
  "IS_SIGNED_3RD_PARTY": "La présentation sera-t-elle signée ou déposée par un tiers au nom du fabricant ou du promoteur?",
  "AUT_LETTER_NOTE": "Une lettre d’autorisation signée par le fabricant ou le promoteur doit être fournie à la section 1.2.1 de la transaction réglementaire.",
  "IS_PRIORITY":"Cette activité de réglementation a-t-elle été approuvée aux fins d’examen prioritaire?",
  "IS_NOC":"Cette activité de réglementation a-t-elle été approuvée aux fins d’examen prioritaire?",
  "IS_ADMIN_SUBMISSION": "Cette activité de réglementation est-elle une présentation administrative ou comporte-t-elle une composante administrative?",
  "ADMIN_DESCRIPT":"Description de la présentation administrative ou de la composante administrative",
  "ADMIN_SUB_TYPE":"Raison justifiant la présentation administrative ou la composante administrative",
  "ACTIVITY_LEAD": "Responsable de l’activité réglementaire",
  "OTHER_DOC_DETAILS": "fr_Other Documentation Details",
  "B14-20160301-09":	"Pharmaceutique",
  "B14-20160301-02":	"Biologique",
  "B14-20160301-10":	"Vigilance après la commercialisation",
  "B14-20160301-06":	"Produit de santé destinés aux consommateurs",
  "RESET": "Réinitialiser",
  "RESET_INFO" : "Si vous souhaitez activer le bouton « Générer le XML final », cliquez sur le bouton « Réinitialiser » pour effacer les renseignements spécifiques à la transaction.",
  "FEE_REMIT_NO_PAYMENT" :"fr_Please remit no payment with this transaction. Payment of the fees will be required upon issuance of an invoice",
  "MITIGATION_TYPE" : "fr_The following mitigation measures are available (select one). Sponsors must certify that they meet the criteria as outlined in the Food and Drug Regulations.",
  "CERTIFY_ORGANIZATION" : "fr_We certify that our organization, including its affiliates, has",
  "CERTIFY_ORGANIZATION_A" : "fr_a) a total number of employees less than 100 people, or",
  "CERTIFY_ORGANIZATION_B" : "fr_b) a total annual gross revenue between $30,000 and $5 million.",
  "SMALL_BUSINESS_FEE_APPLICATION":"fr_We have completed the Small Business Fee Mitigation Application and attached it with our submission/application.",
  "FIRST_SUBMISSION" : "fr_This is my first submission/application",
  "CERTIFY_GOVERMENT_ORGANIZATION" : "fr_We certify that our organization is a branch or agency of the Government of Canada or of a province or territory",
  "CERTIFY_URGENT_HEALTH_NEED":"fr_We certify that the drug in our submission/application is on the List of Drugs for an Urgent Public Health Need as per the Access to Drugs in Exceptional Circumstances Regulations AND",
  "DRUG_THE_SAME_INGREDIENT":"fr_a) the drug has the same medicinal ingredient, strength and route of administration, and is in a comparable dosage form, as a drug that may be imported under subsection C.10.001(2) of those Regulations;",
  "NO_DRUG_IDENTIFICATION_NUMBER":"fr_b) no drug identification number has been assigned under section C.01.014.2 of those Regulations for the drug or for another drug that has the same medicinal ingredient, strength and route of administration and is in a comparable dosage form; and",
  "NO_NOTICE_COMPLIANCE":"fr_c) no notice of compliance has been issued under section C.08.004 of those Regulations in respect of the drug or another drug that has the same medicinal ingredient, strength and route of administration and is in a comparable dosage form.",
  "CERTIFY_FUNDED_HEALTH_INSTITUTION":"fr_We certify that our institution is funded by the Government of Canada or the government of a province or territory and that it is",
  "CERTIFY_FUNDED_HEALTH_INSTITUTION_A":"fr_a) licensed, approved or designated by a province in accordance with the laws of the province to provide care or treatment to persons or animals suffering from any form of disease or illness; or",
  "CERTIFY_FUNDED_HEALTH_INSTITUTION_B":"fr_b) owned or operated by the Government of Canada or the government of a province and that provides health services.",
  "SPONSOR_INVOICE":"fr_Review fees must not be included with the submission, supplement or application. Sponsors will be invoiced for fees of more than $10,000.",
  "COMMENTS_REGULARTORY_DECISION": "Comments on Regulatory Decision Summary"
  "REMISSION_INELIGIBLE": "Vous n’êtes pas admissible à une remise des frais. Les frais de soumission sont inférieurs à 10 % des recettes brutes prévues."
  "DEFER_FEES":" Un paiement différé est demandé avec cette transaction.",
  "IS_FEE_TRANSACTION":"Est-ce que des frais nouveaux ou révisés sont-ils associés avec cette transaction?",
  "REGULATORY_FEES":"Frais",
  "SUB_CLASS":"Catégorie de la présentation",
  "FEE_AMOUNT":"Frais",
  "FEE_DESCRIPTION":"Description de la présentation"
}